New pain program aims to help underserved cancer survivors
NCT ID NCT06063603
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This pilot study tested a pain management program for cancer survivors living in rural areas or of Hispanic background. The program included acupuncture, cognitive behavior therapy, educational materials, and a pain clinic referral. The goal was to see if the program was feasible and acceptable to participants, with the hope of running a larger future trial.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Acupuncture, cognitive behavior therapy, educational materials, and pain clinic referral
- What this could lead to
- If successful, this could lead to a larger trial testing a practical pain management program that helps rural and Hispanic cancer survivors better control their pain.
- What could go wrong
- This is a small pilot study with only 51 participants, so results may not apply to everyone. The program combines several approaches, making it hard to know which part works best.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Can engineered immune cells tackle brain lymphoma?
- Can a new PET tracer reveal hidden immune clues in tumors?